Lung Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.
- Gefitinib for Non-Small Cell Lung Cancer Trial
(Posted: 01/07/2004) - Researchers with this study seek to assess the effectiveness of gefitinib (Iressa) in prolonging the survival of patients who have undergone surgery for stage IB, II, or IIIA non-small cell lung cancer.